SciTransfer
DECIPHER · Project

Quantitative Diagnostic Patch for Rapid Pandemic Testing and Remote Disease Monitoring

healthPrototypeTRL 3

Imagine a smart sticker that acts like a tiny lab on your skin. It uses microscopic needles to collect a drop of fluid and analyzes it instantly without needing a doctor or a big machine. You can read the exact results using a modified glucose meter, making high-tech testing as easy as checking blood sugar.

By the numbers
11
consortium partners
6
countries involved
18%
industry ratio
The business problem

What needed solving

Current quantitative diagnostics require centralized laboratories, making them too slow and expensive for pandemic control. Existing point-of-care tests are often qualitative and require manual sample preparation by trained staff.

The solution

What was built

A microfluidic patch featuring hollow microneedles for self-sampling and integrated analysis, compatible with a re-purposed glucose meter for quantitative results.

Audience

Who needs this

IVD device manufacturersGlobal health NGOsBiomedical polymer producersPandemic preparedness agencies
Business applications

Who can put this to work

Medical Devices
enterprise
Target: Point-of-Care Diagnostic Manufacturer

If you are a diagnostic manufacturer dealing with the high cost and complexity of lab-on-chip devices — this project developed a microfluidic patch that provides quantitative results using a re-purposed glucose meter. This removes the need for expensive laboratory infrastructure and manual sample preparation.

Public Health
any
Target: NGO specializing in infectious disease control

If you are an NGO dealing with high mortality rates from Ebola and Lassa viruses in remote areas — this project developed a self-powered sampling and analysis patch. This allows for immediate, lab-quality diagnosis in regions without electricity or trained technicians.

Advanced Materials
SME
Target: Polymer Manufacturing Firm

If you are a materials company dealing with the slow production speeds of traditional microfluidics — this project developed high-throughput manufacturing processes based on novel photopolymers. This enables the roll-to-roll production of diagnostic patches at scale.

Frequently asked

Quick answers

What is the estimated cost or price of the device?

Based on available project data, specific pricing is not mentioned, but the project aims to reduce costs by using roll-to-roll manufacturing and re-purposing existing glucose meters.

Can this be produced at an industrial scale?

Yes, the project specifically focuses on high-throughput manufacturing processes using roll-to-roll techniques and novel photopolymers to ensure scalability.

How is the IP and licensing handled?

Based on available project data, there is no specific information regarding licensing terms or patent filings.

What is the timeline for market entry?

The project period runs from 2024-01-01 to 2027-12-31, suggesting a development and validation cycle over four years.

How does the device integrate with existing health systems?

The system integrates by using a re-purposed glucose meter for readout and incorporates AI-based models and socio-economic analysis for effective field implementation.

Consortium

Who built it

The consortium is heavily weighted toward research and academia, with 4 universities and 4 research institutes. However, it maintains a practical edge with 2 industry partners (including 2 SMEs) and 1 NGO, ensuring that the 11 partners across 6 countries cover the entire value chain from polymer science to field implementation in high-risk zones.

How to reach the team

Contact the Katholieke Universiteit Leuven research office regarding the DECIPHER project.

Next steps

Talk to the team behind this work.

Contact SciTransfer for detailed partnership matchmaking with the DECIPHER consortium.

More in Health & Biomedical
See all Health & Biomedical projects